Source: Reuters The U.S. Food and Drug Administration on Wednesday said it approved Pfizer Inc's (PFE.N) ointment to treat mild to moderate cases of the itchy skin condition eczema, or atopic dermatitis, for use in patients aged two years and older. Atopic dermatitis is the most common of the many…...